Sh-Polypeptide-1 for Hair Regrowth - Quick Reference Sheet

Sh-Polypeptide-1 for Hair Regrowth

Created on 08/02/2026 – Quick Reference based on Evidence Review created using AI4L / Opus 4.8 Audit

A lab-made copy of a natural repair protein that signals follicle cells to multiply and builds blood supply around them. Early human evidence is modestly encouraging, but mainly as an add-on to other treatments rather than a stand-alone therapy. Side effects are mostly mild and local. Its independent value remains genuinely uncertain. (Full Review)

Protocol

Topical Serum
~3500 IU, 2× daily
With 1 mL of 5% minoxidil, on a dry scalp after cleansing
Clinic Delivery
Microneedling / mesotherapy
Intradermal sessions overcome poor skin penetration
Surgical Adjunct
Transplant graft support
Graft immersion plus post-operative topical application
Time to effect
Graft Survival
12 months
Transplant follicle survival assessed at one year
Density Gains
3–6 months
Density or caliber differences match the hair-cycle pace
Minoxidil Combo
6 months
Higher responder rate versus minoxidil alone

Benefits

Contraindications
  • Active scalp malignancy or premalignant scalp lesions (squamous or basal cell carcinoma, actinic keratosis)
  • Known hypersensitivity to the recombinant protein or vehicle
  • Pregnancy or breastfeeding
  • Active scalp infection or inflammatory scalp disease
Key Interactions
  • Anticoagulants and antiplatelet drugs (warfarin, apixaban, clopidogrel, aspirin)
  • Topical exfoliants or retinoids

Risk & Side Effects

  • Medium: Application-site irritation
  • Low: Procedure-related effects from injection or microneedling, theoretical tumor-promotion and angiogenesis concern
  • Speculative: Immunogenicity to the recombinant protein, unwanted hair growth at application margins, unknown long-term safety of chronic use

Monitoring

Marker Target Why
Ferritin (iron stores) 40–70 ng/mL Low iron stores impair regrowth and cause shedding
Vitamin D (25-OH) 40–60 ng/mL Deficiency is linked to hair thinning and follicle cycling
TSH 0.5–2.5 mIU/L Thyroid dysfunction causes diffuse hair loss
Serum zinc 90–120 µg/dL Zinc deficiency contributes to shedding and weak hair
Testosterone / DHT (women with pattern loss) Sex-specific reference, low-normal preferred Screens for androgen excess driving miniaturization

Cadence: Baseline, 3, 6, and 12 months, then every 6–12 months for maintenance

Qualitative Assessment

  • Reduced daily shedding (fewer hairs on the pillow, in the shower drain, or on the comb)
  • Increased hair caliber and a fuller feel to existing hair
  • Visible new short regrowth ("baby hairs") along thinning zones or the hairline
  • Improved scalp coverage on standardized photographs
  • Subjective confidence in hair appearance